• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对来自非洲绿猴的猿猴免疫缺陷病毒无致病性基础的免疫学研究。

Immunological studies of the basis for the apathogenicity of simian immunodeficiency virus from African green monkeys.

作者信息

Norley S G, Kraus G, Ennen J, Bonilla J, König H, Kurth R

机构信息

Paul-Ehrlich-Institut, Langen, Federal Republic of Germany.

出版信息

Proc Natl Acad Sci U S A. 1990 Nov;87(22):9067-71. doi: 10.1073/pnas.87.22.9067.

DOI:10.1073/pnas.87.22.9067
PMID:2247482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC55102/
Abstract

Potential reasons for the lack of pathogenicity of the simian immunodeficiency virus SIVagm in its natural host, the African green monkey (AGM, Cercopithecus aethiops), were investigated with respect to immunological mechanisms. The functional immune response of monkeys to infection was similar (though not identical) to that of humans to infection with human immunodeficiency virus type 1 (HIV-1). In the sera of infected animals, neutralizing antibodies were found to be low or absent, and in particular there was no neutralization of the various isolates by homologous sera. There was no detectable antibody/complement cytotoxicity, though AGM sera were able to initiate antibody-dependent cellular cytolysis of infected cells in the presence of healthy effector peripheral blood lymphocytes. As in the human/HIV system, macrophages from AGMs are readily infected by SIVagm. Two possibly important differences between the AGM/SIVagm system and the human/HIV system are (i) the low immune response of the AGMs to the core protein of SIVagm and (ii) the significantly lower inhibitory effect of SIVagm proteins on the proliferation of AGM lymphocytes.

摘要

针对免疫机制,研究了猿猴免疫缺陷病毒SIVagm在其天然宿主非洲绿猴(AGM,猕猴属埃塞俄比亚猕猴)中缺乏致病性的潜在原因。猴子对感染的功能性免疫反应与人类对1型人类免疫缺陷病毒(HIV-1)感染的反应相似(尽管不完全相同)。在受感染动物的血清中,发现中和抗体水平较低或不存在,特别是同源血清对各种分离株没有中和作用。虽然AGM血清在健康效应外周血淋巴细胞存在的情况下能够引发对感染细胞的抗体依赖性细胞溶解,但未检测到抗体/补体细胞毒性。与人类/HIV系统一样,AGM的巨噬细胞很容易被SIVagm感染。AGM/SIVagm系统与人类/HIV系统之间可能存在的两个重要差异是:(i)AGM对SIVagm核心蛋白的免疫反应较低;(ii)SIVagm蛋白对AGM淋巴细胞增殖的抑制作用明显较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0897/55102/43f759fb9fd5/pnas01047-0392-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0897/55102/6cd3a607a5a5/pnas01047-0392-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0897/55102/48b702a30532/pnas01047-0392-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0897/55102/43e6703861aa/pnas01047-0392-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0897/55102/43f759fb9fd5/pnas01047-0392-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0897/55102/6cd3a607a5a5/pnas01047-0392-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0897/55102/48b702a30532/pnas01047-0392-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0897/55102/43e6703861aa/pnas01047-0392-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0897/55102/43f759fb9fd5/pnas01047-0392-d.jpg

相似文献

1
Immunological studies of the basis for the apathogenicity of simian immunodeficiency virus from African green monkeys.对来自非洲绿猴的猿猴免疫缺陷病毒无致病性基础的免疫学研究。
Proc Natl Acad Sci U S A. 1990 Nov;87(22):9067-71. doi: 10.1073/pnas.87.22.9067.
2
CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine.非洲绿猴的CD8 + T淋巴细胞分泌一种抑制免疫缺陷病毒的淋巴因子。
Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7207-11. doi: 10.1073/pnas.91.15.7207.
3
SIVagm infection of its natural African green monkey host.猴免疫缺陷病毒对其自然宿主非洲绿猴的感染。
Immunol Lett. 1996 Jun;51(1-2):53-8. doi: 10.1016/0165-2478(96)02555-2.
4
Neither whole inactivated virus immunogen nor passive immunoglobulin transfer protects against SIVagm infection in the African green monkey natural host.无论是全灭活病毒免疫原还是被动免疫球蛋白转移,都无法保护非洲绿猴自然宿主免受猴免疫缺陷病毒(SIVagm)感染。
J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Mar 1;8(3):217-26. doi: 10.1097/00042560-199503010-00001.
5
Neutralizing antibody responses in Africa green monkeys naturally infected with simian immunodeficiency virus (SIVagm).自然感染猿猴免疫缺陷病毒(SIVagm)的非洲绿猴的中和抗体反应。
J Med Primatol. 1999 Jun;28(3):97-104. doi: 10.1111/j.1600-0684.1999.tb00257.x.
6
The role of the immune response during SIVagm infection of the African green monkey natural host.免疫反应在非洲绿猴自然宿主感染猴免疫缺陷病毒(SIVagm)过程中的作用。
Front Biosci. 2004 Jan 1;9:550-64. doi: 10.2741/1219.
7
Simian immunodeficiency virus infection in a patas monkey (Erythrocebus patas): evidence for cross-species transmission from African green monkeys (Cercopithecus aethiops sabaeus) in the wild.一只赤猴(赤猴属赤猴)感染猿猴免疫缺陷病毒:野生非洲绿猴(猕猴属埃塞俄比亚亚种)跨物种传播的证据。
J Gen Virol. 1996 Apr;77 ( Pt 4):773-81. doi: 10.1099/0022-1317-77-4-773.
8
Simian immunodeficiency virus SIVagm.sab infection of Caribbean African green monkeys: a new model for the study of SIV pathogenesis in natural hosts.猿猴免疫缺陷病毒SIVagm.sab对加勒比非洲绿猴的感染:一种研究自然宿主中SIV发病机制的新模型。
J Virol. 2006 May;80(10):4858-67. doi: 10.1128/JVI.80.10.4858-4867.2006.
9
DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus SIVagm.来自非洲绿猴的DC-SIGN在淋巴结中表达,并介导猴免疫缺陷病毒SIVagm的跨细胞感染。
J Virol. 2004 Jan;78(2):798-810. doi: 10.1128/jvi.78.2.798-810.2004.
10
Envelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virus.慢性感染猴免疫缺陷病毒的非洲绿猴体内的信封特异性 B 细胞群体。
Nat Commun. 2016 Jul 6;7:12131. doi: 10.1038/ncomms12131.

引用本文的文献

1
NK cell spatial dynamics and IgA responses in gut-associated lymphoid tissues during SIV infections.SIV 感染期间肠道相关淋巴组织中 NK 细胞的空间动态和 IgA 反应。
Commun Biol. 2022 Jul 7;5(1):674. doi: 10.1038/s42003-022-03619-y.
2
Predominant envelope variable loop 2-specific and gp120-specific antibody-dependent cellular cytotoxicity antibody responses in acutely SIV-infected African green monkeys.急性 SIV 感染的非洲绿猴中优势包膜可变环 2 特异性和 gp120 特异性抗体依赖性细胞细胞毒性抗体反应。
Retrovirology. 2018 Mar 9;15(1):24. doi: 10.1186/s12977-018-0406-5.
3
T cell independent secondary antibody responses to the envelope protein of simian immunodeficiency virus.

本文引用的文献

1
Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120.人类体内缺乏针对人类免疫缺陷病毒感染细胞的细胞毒性抗体,以及在动物感染或用纯化包膜糖蛋白gp120免疫后诱导产生该抗体的情况。
Proc Natl Acad Sci U S A. 1987 Jun;84(11):3797-801. doi: 10.1073/pnas.84.11.3797.
2
Type-restricted neutralization of molecular clones of human immunodeficiency virus.人免疫缺陷病毒分子克隆的型特异性中和作用
Science. 1988 Jul 15;241(4863):357-9. doi: 10.1126/science.3388046.
3
Simian immunodeficiency virus from African green monkeys.
T 细胞非依赖的针对猴免疫缺陷病毒包膜蛋白的次级抗体应答。
Retrovirology. 2012 May 14;9:42. doi: 10.1186/1742-4690-9-42.
4
Effect of B-cell depletion on viral replication and clinical outcome of simian immunodeficiency virus infection in a natural host.B细胞耗竭对自然宿主中猿猴免疫缺陷病毒感染的病毒复制及临床结局的影响。
J Virol. 2009 Oct;83(20):10347-57. doi: 10.1128/JVI.00880-09. Epub 2009 Aug 5.
5
Transcriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization.致病性和非致病性猴免疫缺陷病毒感染中的转录谱分析揭示了动力学和组织区室化方面的显著差异。
PLoS Pathog. 2009 Feb;5(2):e1000296. doi: 10.1371/journal.ppat.1000296. Epub 2009 Feb 13.
6
Gag p27-specific B- and T-cell responses in Simian immunodeficiency virus SIVagm-infected African green monkeys.猿猴免疫缺陷病毒SIVagm感染的非洲绿猴中针对Gag p27的B细胞和T细胞反应
J Virol. 2009 Mar;83(6):2770-7. doi: 10.1128/JVI.01841-08. Epub 2008 Dec 24.
7
Early divergence in lymphoid tissue apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates.非人灵长类动物致病性和非致病性猿猴免疫缺陷病毒感染中淋巴组织凋亡的早期差异。
J Virol. 2008 Feb;82(3):1175-84. doi: 10.1128/JVI.00450-07. Epub 2007 Nov 21.
8
Going wild: lessons from naturally occurring T-lymphotropic lentiviruses.走向狂野:来自天然存在的嗜T淋巴细胞慢病毒的启示。
Clin Microbiol Rev. 2006 Oct;19(4):728-62. doi: 10.1128/CMR.00009-06.
9
Simian immunodeficiency virus SIVagm.sab infection of Caribbean African green monkeys: a new model for the study of SIV pathogenesis in natural hosts.猿猴免疫缺陷病毒SIVagm.sab对加勒比非洲绿猴的感染:一种研究自然宿主中SIV发病机制的新模型。
J Virol. 2006 May;80(10):4858-67. doi: 10.1128/JVI.80.10.4858-4867.2006.
10
Direct inoculation of simian immunodeficiency virus from sooty mangabeys in black mangabeys (Lophocebus aterrimus): first evidence of AIDS in a heterologous African species and different pathologic outcomes of experimental infection.将来自乌黑白眉猴的猴免疫缺陷病毒直接接种到黑冠白眉猴(Lophocebus aterrimus)体内:首例在异种非洲物种中出现艾滋病的证据以及实验性感染的不同病理结果
J Virol. 2004 Nov;78(21):11506-18. doi: 10.1128/JVI.78.21.11506-11518.2004.
来自非洲绿猴的猿猴免疫缺陷病毒。
J Virol. 1988 Nov;62(11):4123-8. doi: 10.1128/JVI.62.11.4123-4128.1988.
4
Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.持续的HIV抗原血症以及与向艾滋病转变相关的HIV核心抗体下降。
Br Med J (Clin Res Ed). 1986 Dec 6;293(6560):1459-62. doi: 10.1136/bmj.293.6560.1459.
5
Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack.人类嗜T细胞病毒IIIB型糖蛋白(gp120)与正常淋巴细胞上的CD4决定簇结合,并由受感染细胞表达,成为免疫攻击的靶标。
Proc Natl Acad Sci U S A. 1987 Jul;84(13):4601-5. doi: 10.1073/pnas.84.13.4601.
6
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection.人类免疫缺陷病毒感染中特异性细胞介导免疫反应的特征
J Virol. 1987 Jun;61(6):2017-23. doi: 10.1128/JVI.61.6.2017-2023.1987.
7
HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis.人嗜T淋巴细胞病毒III型大包膜蛋白(糖蛋白120)抑制PHA诱导的淋巴细胞增殖。
J Immunol. 1987 Apr 15;138(8):2640-4.
8
Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes.人类免疫缺陷病毒对正常B淋巴细胞的刺激和抑制作用。
Proc Natl Acad Sci U S A. 1986 Dec;83(23):9124-8. doi: 10.1073/pnas.83.23.9124.
9
The role of mononuclear phagocytes in HTLV-III/LAV infection.单核吞噬细胞在人类嗜T淋巴细胞病毒III型/淋巴腺病相关病毒感染中的作用。
Science. 1986 Jul 11;233(4760):215-9. doi: 10.1126/science.3014648.
10
AIDS: animal retrovirus models and vaccines.艾滋病:动物逆转录病毒模型与疫苗
J Acquir Immune Defic Syndr (1988). 1988;1(3):284-94.